Oracort and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Oracort (triamcinolone acetonide), especially for people who are female, 50-59 old, also take Synthroid, and have Crohn's disease.

The phase IV clinical study analyzes which people have Weakness when taking Oracort. It is created by eHealthMe based on reports of 174 people who have side effects when taking Oracort from the FDA, and is updated regularly.

What is Oracort?

Oracort has active ingredients of triamcinolone acetonide. eHealthMe is studying from 175 Oracort users. Check the latest studies of Oracort.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

174 people reported to have side effects when taking Oracort.
Among them, 19 people (10.92%) have Weakness.

Among these 19 people:

What is the gender of people who have Weakness when taking Oracort? *

female: 78.95 %
male: 21.05 %

What is the age of people who have Weakness when taking Oracort? *

What are other drugs people take besides Oracort? *

What are other side effects people have besides Weakness? *

Back Pain: 15 people, 78.95%
Weight Decreased: 15 people, 78.95%
Hypoaesthesia (reduced sense of touch or sensation): 13 people, 68.42%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 13 people, 68.42%
Abdominal Pain Upper: 13 people, 68.42%
Sluggishness (lacking alertness): 13 people, 68.42%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 13 people, 68.42%
Feeding Disorder (when children refuse to eat certain food groups): 13 people, 68.42%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 13 people, 68.42%
Fluid Intake Reduced: 13 people, 68.42%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 13 people, 68.42%
Indigestion: 13 people, 68.42%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 13 people, 68.42%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 4 people, 21.05%
Migraine (headache): 2 people, 10.53%
Iron Overload: 2 people, 10.53%
Breast Cancer Metastatic: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Oracort and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oracort:

Oracort (175 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Oracort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Oracort) and Oracort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.